Intrasurgical tissue engineering of autologous grafts using irreversible electroporation for bladder reconstruction
使用不可逆电穿孔进行膀胱重建的自体移植物的术中组织工程
基本信息
- 批准号:10652429
- 负责人:
- 金额:$ 33.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-12 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAgonistAutologous TransplantationBasement membraneBiochemicalBiocompatible MaterialsBioreactorsBladderBlood VesselsCell Death InductionCell Differentiation processCellsCicatrixClinicClinicalCongenital DisordersDataDevelopmentElectroporationEngineeringEsophagusExtracellular MatrixFamily suidaeFrequenciesFunctional RegenerationGastrointestinal tract structureHeterogeneityHistocompatibilityImmunohistochemistryImpairmentIn VitroInflammationIntestinesKnowledgeMalignant NeoplasmsMalignant neoplasm of urinary bladderMechanicsMetabolicMetabolic acidosisModelingMolecular Biology TechniquesMorbidity - disease rateMucous MembraneNatural regenerationNeurogenic BladderNon-MalignantOperative Surgical ProceduresOrganPathway interactionsPatientsPelvisPerfusionPhenotypePhysiologic pulsePhysiologicalPiezo 1 ion channelPopulationProductionRattusReconstructive Surgical ProceduresRegenerative MedicineResearchResearch DesignRiskRoleSafetySecond Primary CancersSmall Intestinal SubmucosaSmooth Muscle MyocytesSourceStretchingTechniquesTechnologyTissue EngineeringTissuesTracheaTranslatingTranslationsTubular formationUrinary DiversionUrotheliumWorkbladder surgerycell killingefficacy evaluationelectric fieldimprovedimproved outcomein silicoin vivoinnovationknock-downmanufacturemechanotransductionnew technologynovelporcine modelpreservationreconstructionresponsestandard of caretissue support frametooltumor ablationurinaryurogenital tractvoltage
项目摘要
PROJECT SUMMARY
Bladder reconstruction (BR) is essential to restore urinary function in patients with neurogenic bladder,
congenital disorders, and as sequalae to the surgical treatment of bladder or pelvic malignancies. The current
standard of care is to use the patient's own intestinal tissue (ileal segment; IS) as graft material during BR to
create a neobladder or urinary diversion. While IS grafts are non-immunogenic and readily available, post-
surgical persistence of intestinal cells in the graft impedes regeneration into bladder wall, resulting in stone
formation, metabolic acidosis and risk of secondary cancers. Our objective is to develop new technology for
intrasurgical tissue engineering of the IS by knockdown of cellular components using irreversible
electroporation (IRE) and identify factors fundamental for regeneration of functional bladder wall. IRE is used in
patients for tumor ablation by inducing cell death with ultrashort electric pulses. Our proposed strategy builds
upon our preliminary data showing (i) IRE can knockdown intestinal cells in an IS graft, aiding repopulation
with urothelium in a rat model of BR, (ii) feasibility of new pulse application strategies for the focal knockdown
of mucosa, or decellularization while preserving vasculature and ECM in the IS, and (iii) phenotypic changes in
IRE treated IS following urothelialization, that were not observed in sham controls under physiologic conditions
of bladder filling and voiding. In specific aim 1, we will Define the impact of graft perfusion on bladder wall
regeneration by performing vasculature sparing IRE of the IS. In specific aim 2, Elucidate the role of IS
mucosa in post-BR complications by knockdown with IRE. In specific aim 3, Investigate the role of
mechanotransduction in bladder function development in IRE treated IS. Intrasurgical creation of a perfused,
histocompatible graft (Aim 1) and focal decellularization of the mucosa while sparing the underlying layers in
the IS (Aim 2) are the first examples of in vivo knockdown tissue engineering using IRE. The study and
application of mechanotransduction principles to augment urinary barrier function development in IS grafts
(Aim 3) is previously undescribed. Knowledge gained from proposed research will yield a simple intrasurgical
technique (mt-IRE or vs-IRE) that combines technology (IRE) and grafting technique (with IS) that are already
in the clinic, enabling rapid translation for the immediate benefit of patients undergoing BR. Eventually, we
anticipate our work to advance the concept of in vivo production of functionalized grafts using the patient as the
source of biomaterial and the bioreactor, with application to reconstructive surgery involving other tubular
organs such as the esophagus, trachea or large blood vessels.
项目摘要
膀胱重建(BR)对于恢复神经源性膀胱患者的尿功能至关重要,
先天性疾病,作为膀胱或骨盆恶性肿瘤手术治疗的序列。电流
护理标准是将患者自己的肠组织(iLeal片段; is)用作BR期间的移植物材料
创建新蓝色或尿液转移。虽然是移植物是非免疫原性的,而且很容易获得
移植物中肠细胞的手术持久性阻碍了再生到膀胱壁,导致石头
形成,代谢性酸中毒和继发性癌症的风险。我们的目标是为
通过使用不可逆的细胞成分敲低细胞成分
电穿孔(IRE)并确定功能膀胱壁再生的因素。 ire被用
通过用超短脉冲诱导细胞死亡来消融肿瘤的患者。我们提出的策略建立
在我们的初步数据上,显示(i)可以敲除肠道中的肠细胞,以帮助重生
在BR大鼠模型中使用尿皮上皮,(ii)新的脉冲应用策略的可行性
在IS中保留脉管系统和ECM的同时,(iii)表型变化
经过治疗的尿路上皮化是在生理条件下在假对照中观察到的
膀胱填充和排尿。在特定目标1中,我们将定义移植物灌注对膀胱壁的影响
通过进行脉管系统的再生,使IS的更新。在特定目标2中,阐明了IS的作用
通过与IRE敲除后BR并发症中的粘膜。在特定目标3中,调查
IRE处理的IRE的膀胱功能发育的机械转导IS。灌注,
组织兼容的移植物(AIM 1)和粘膜的局灶性脱细胞,同时占据下层层
IS(AIM 2)是使用IRE的体内敲低组织工程的第一个例子。研究和
机械转移原理在增加尿路屏障功能开发中的应用是移植物
(AIM 3)以前未描述。从提议的研究中获得的知识将产生简单的外科内部
结合了技术(IRE)和嫁接技术的技术(MT-IRE或VS-IRE)(使用IS)
在诊所中,可以快速翻译为接受BR的患者的直接益处。最终,我们
预期我们的工作以利用患者为
生物材料和生物反应器的来源,并应用于涉及其他管状的重建手术
器官,例如食道,气管或大血管。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Directional Cell Migration Guided by a Strain Gradient.
由应变梯度引导的定向细胞迁移。
- DOI:10.1002/smll.202302404
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Yang,Feiyu;Chen,Pengcheng;Jiang,Han;Xie,Tianfa;Shao,Yue;Kim,Deok-Ho;Li,Bo;Sun,Yubing
- 通讯作者:Sun,Yubing
Acute ATP loss during irreversible electroporation mediates caspase independent cell death.
不可逆电穿孔过程中急性 ATP 损失介导不依赖半胱天冬酶的细胞死亡。
- DOI:10.1016/j.bioelechem.2022.108355
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Razakamanantsoa,Leo;Rajagopalan,NeerajR;Kimura,Yasushi;Sabbah,Michele;Thomassin-Naggara,Isabelle;Cornelis,FrançoisH;Srimathveeravalli,Govindarajan
- 通讯作者:Srimathveeravalli,Govindarajan
Imaging and detecting intercellular tensile forces in spheroids and embryoid bodies using lipid-modified DNA probes.
- DOI:10.3389/fcell.2023.1220079
- 发表时间:2023
- 期刊:
- 影响因子:5.5
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Govindarajan Srimathveeravalli其他文献
Govindarajan Srimathveeravalli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Govindarajan Srimathveeravalli', 18)}}的其他基金
Intrasurgical tissue engineering of autologous grafts using irreversible electroporation for bladder reconstruction
使用不可逆电穿孔进行膀胱重建的自体移植物的术中组织工程
- 批准号:
10277714 - 财政年份:2021
- 资助金额:
$ 33.79万 - 项目类别:
Intrasurgical tissue engineering of autologous grafts using irreversible electroporation for bladder reconstruction
使用不可逆电穿孔进行膀胱重建的自体移植物的术中组织工程
- 批准号:
10447720 - 财政年份:2021
- 资助金额:
$ 33.79万 - 项目类别:
相似国自然基金
内源激动剂ArA靶向TMEM175蛋白缓解帕金森病症的分子机制研究
- 批准号:32300565
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Adrb2激动剂在改善呼吸机相关性膈肌功能障碍中的作用与机制研究
- 批准号:82372196
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于OSMAC-GNPS分析策略的蚂蚱内生真菌Aspergillus sp.中新颖泛PPAR激动剂的发现及治疗NASH研究
- 批准号:82304340
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
探究FSP1激动剂在治疗肾缺血再灌注损伤中的分子机理与应用
- 批准号:82304600
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Specialized Proresolving Lipid Mediator-Enhanced Stem Cell Therapy and Tissue Regeneration
专门的溶解脂质介质增强干细胞治疗和组织再生
- 批准号:
10659020 - 财政年份:2022
- 资助金额:
$ 33.79万 - 项目类别:
Development of 3D Printed Synthetic Bone Graft Containing Small Molecules for Sequential Activation of Hedgehog and Hypoxia Signaling for Treatment of Nonunion Fractures
开发含有小分子的 3D 打印合成骨移植物,用于顺序激活 Hedgehog 和缺氧信号,用于治疗骨不连骨折
- 批准号:
10664885 - 财政年份:2021
- 资助金额:
$ 33.79万 - 项目类别:
Recapitulating developmental pathways to improve iPSC-RPE derivation protocols
概括改进 iPSC-RPE 衍生方案的发育途径
- 批准号:
8060452 - 财政年份:2010
- 资助金额:
$ 33.79万 - 项目类别:
Recapitulating developmental pathways to improve iPSC-RPE derivation protocols
概括改进 iPSC-RPE 衍生方案的发育途径
- 批准号:
8289394 - 财政年份:2010
- 资助金额:
$ 33.79万 - 项目类别:
Recapitulating developmental pathways to improve iPSC-RPE derivation protocols
概括改进 iPSC-RPE 衍生方案的发育途径
- 批准号:
8389544 - 财政年份:2010
- 资助金额:
$ 33.79万 - 项目类别: